Arlington Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Sell |
20,417
-7,308
| -26% | -$918K | 0.95% | 54 |
|
|
2025
Q1 | $3.79M | Buy |
+27,725
| New | +$3.79M | 1.49% | 44 |
|
|
2024
Q4 | – | Sell |
-19,214
| Closed | -$3.72M | – | 59 |
|
|
2024
Q3 | $3.72M | Buy |
19,214
+4,902
| +34% | +$950K | 1.46% | 53 |
|
|
2024
Q2 | $3.32M | Buy |
14,312
+1,823
| +15% | +$423K | 1.65% | 14 |
|
|
2024
Q1 | $2.69M | Buy |
12,489
+833
| +7% | +$180K | 1.37% | 52 |
|
|
2023
Q4 | $3.02M | Buy |
+11,656
| New | +$3.02M | 0.87% | 39 |
|
|
2023
Q3 | – | Sell |
-5,025
| Closed | -$1.43M | – | 378 |
|
|
2023
Q2 | $1.43M | Sell |
5,025
-50
| -1% | -$14.2K | 0.22% | 45 |
|
|
2023
Q1 | $1.41M | Sell |
5,075
-204
| -4% | -$56.7K | 0.2% | 41 |
|
|
2022
Q4 | $1.46M | Sell |
5,279
-1,356
| -20% | -$376K | 0.23% | 40 |
|
|
2022
Q3 | $1.77M | Buy |
6,635
+116
| +2% | +$31K | 0.71% | 31 |
|
|
2022
Q2 | $1.33M | Sell |
6,519
-985
| -13% | -$201K | 0.44% | 41 |
|
|
2022
Q1 | $1.58M | Sell |
7,504
-1,486
| -17% | -$313K | 0.45% | 42 |
|
|
2021
Q4 | $2.16M | Buy |
8,990
+232
| +3% | +$55.7K | 0.58% | 38 |
|
|
2021
Q3 | $2.48M | Buy |
8,758
+488
| +6% | +$138K | 0.71% | 32 |
|
|
2021
Q2 | $2.86M | Sell |
8,270
-43
| -0.5% | -$14.9K | 0.99% | 20 |
|
|
2021
Q1 | $2.33M | Buy |
8,313
+753
| +10% | +$211K | 0.85% | 26 |
|
|
2020
Q4 | $1.85M | Buy |
7,560
+13
| +0.2% | +$3.18K | 0.85% | 28 |
|
|
2020
Q3 | $2.14M | Hold |
7,547
| – | – | 1.17% | 20 |
|
|
2020
Q2 | $2.02M | Buy |
7,547
+630
| +9% | +$169K | 1.13% | 20 |
|
|
2020
Q1 | $2.19M | Buy |
6,917
+5,452
| +372% | +$1.72M | 1.14% | 20 |
|
|
2019
Q4 | $435K | Buy |
1,465
+330
| +29% | +$98K | 0.27% | 33 |
|
|
2019
Q3 | $264K | Sell |
1,135
-7,011
| -86% | -$1.63M | 0.17% | 44 |
|
|
2019
Q2 | $1.91M | Buy |
8,146
+7,631
| +1,482% | +$1.78M | 0.85% | 30 |
|
|
2019
Q1 | $122K | Sell |
515
-1,895
| -79% | -$449K | 0.09% | 89 |
|
|
2018
Q4 | $725K | Buy |
2,410
+120
| +5% | +$36.1K | 0.47% | 40 |
|
|
2018
Q3 | $809K | Buy |
2,290
+25
| +1% | +$8.83K | 0.57% | 37 |
|
|
2018
Q2 | $657K | Hold |
2,265
| – | – | 0.62% | 40 |
|
|
2018
Q1 | $620K | Buy |
2,265
+225
| +11% | +$61.6K | 0.58% | 39 |
|
|
2017
Q4 | $650K | Buy |
+2,040
| New | +$650K | 0.67% | 39 |
|